Estimates Revisions Recursion Pharmaceuticals, Inc. Mexican S.E.
Stocks
RXRX *
US75629V1044
Biotechnology & Medical Research
|
End-of-day quote
Mexican S.E.
2026-08-07
|
5-day change | 1st Jan Change | ||
| 54.89 MXN | -3.36% |
|
-1.60% | -25.71% |
| 08-11 | Recursion Pharmaceuticals, Inc. Presents at Bank of America SMID Cap Virtual Conference, Aug-11-2026 10:00 AM | |
| 08-05 | Recursion Pharmaceuticals, Inc., Q2 2026 Earnings Call, Aug 05, 2026 |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- RXRX Stock
- RXRX * Stock
- Consensus Recursion Pharmaceuticals, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
